Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patency Rate”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06369064
What this trial is testing

Continuous Veno-venous Hemodialysis and Continuous Veno-venous Hemodiafiltration on Urea Reduction Rate in Intensive Care Patient

Who this might be right for
Acute Kidney InjuryContinuous Renal Replacement TherapyIntensive Care Unit
Centre Hospitalier Universitaire de Nīmes 80
Large-scale testing (Phase 3)UnknownNCT02952976
What this trial is testing

Study of Primary Fascial Closure Rate in Patients With Open Abdomen Treated With Abthera Versus Barker Technique

Who this might be right for
Abdominal TraumaAbdominal SepsisAbdominal Compartment Syndrome
Sociedade Brasileira de Atendimento Integrado ao Trauma 94
Not applicableStudy completedNCT02732340
What this trial is testing

Triple-branch Stent Graft Placement for the Treatment of Acute DeBakey I Aortic Dissection

Who this might be right for
Acute Aortic Dissection
Fujian Medical University 196
Early research (Phase 1)Study completedNCT00815607
What this trial is testing

Trial of an Intratumoral Injections of INXN-3001 in Subjects With Stage III or IV Melanoma

Who this might be right for
Melanoma
Alaunos Therapeutics 12
Testing effectiveness (Phase 2)Study completedNCT03148795
What this trial is testing

Talazoparib in Men With DNA Repair Defects and Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Pfizer 128
Post-approval studies (Phase 4)Study completedNCT00727961
What this trial is testing

Evaluate Efficacy and Tolerance of Caelyx in Patients With Epithelial Ovarian Cancer. (Study P04072)(COMPLETED)

Who this might be right for
Ovarian Neoplasms
Merck Sharp & Dohme LLC 58
Not applicableStudy completedNCT03275883
What this trial is testing

Arterial Patency in Liver Transplantation

Who this might be right for
Aortohepatic ConduitPatency RateLiver Transplantation
University of Zurich 567
Large-scale testing (Phase 3)Looking for participantsNCT06520345
What this trial is testing

The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global)

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Telix Pharmaceuticals (Innovations) Pty Limited 520
Testing effectiveness (Phase 2)Study completedNCT00545688
What this trial is testing

Pertuzumab in Combination With Herceptin in Patients With HER2 Positive Breast Cancer.

Who this might be right for
Breast Cancer
Hoffmann-La Roche 417
Not applicableUnknownNCT01136551
What this trial is testing

Comparative Bioavailability Study of an Immediate Release and Controlled Release Oral Formulations of Huperzine A

Who this might be right for
HealthyBioavailability
Hadassah Medical Organization 8
Large-scale testing (Phase 3)WithdrawnNCT03619187
What this trial is testing

An Interventional Study to Evaluate the Effect of Ivabradine on Exercise Capacity in Heart Transplant Recipients

Who this might be right for
Heart Transplantation, Elevated Resting Heart Rate
Amgen
Testing effectiveness (Phase 2)Study completedNCT02880007
What this trial is testing

Dose Optimization in 3D Pulsed Dose Rate Brachytherapy for Patients With Locally Advanced Cervical Cancer

Who this might be right for
Cervical AdenocarcinomaStage IB Cervical CancerStage II Cervical Cancer+1 more
Institut de Cancérologie de Lorraine 48
Early research (Phase 1)Study completedNCT04372719
What this trial is testing

Determine the Safety and Attack Rate of the Seasonal Flu in Healthy Volunteers

Who this might be right for
Influenza, Human
SGS Life Sciences, a division of SGS Belgium NV 36
Not applicableUnknownNCT03527602
What this trial is testing

FE in Anterior Teeth

Who this might be right for
Pain, PostoperativeApical Periodontitis
Isparta Military Hospital 40
Early research (Phase 1)Study completedNCT00358371
What this trial is testing

Bioavailability Of Flucloxacillin Capsules (250 mg and 500 mg)

Who this might be right for
Infections, Bacterial
GlaxoSmithKline 24
Testing effectiveness (Phase 2)Ended earlyNCT00576901
What this trial is testing

Avastin (Bevacizumab) in Combination With Xeloda (Capecitabine) and Docetaxel in Patients With Inflammatory or Locally Advanced Breast Cancer.

Who this might be right for
Breast Cancer
Hoffmann-La Roche 23
Not applicableWithdrawnNCT02047422
What this trial is testing

A Prospective, Single-center, Randomized, Controlled, Open-label, Pilot Study to Compare the Effectiveness and Safety of DIuretics Add-On Strategy in Acute Decompensated Heart Failure Patients (DIOS II)

Who this might be right for
Congestive Heart Failure
Yonsei University
Large-scale testing (Phase 3)Study completedNCT00196729
What this trial is testing

Comparison of the Safety and Successful Ablation of Thyroid Remnant in Post-thyroidectomized Euthyroid Patients (i.e. Patients Administered Thyrogen) Versus Hypothyroid Patients (no Thyrogen) Following 131I Administration

Who this might be right for
Thyroid Neoplasms
Genzyme, a Sanofi Company 63
Large-scale testing (Phase 3)Study completedNCT04948333
What this trial is testing

Asciminib Treatment Optimization in ≥ 3rd Line CML-CP

Who this might be right for
Chronic Myelogenous Leukemia
Novartis Pharmaceuticals 199
Large-scale testing (Phase 3)Ended earlyNCT00425438
What this trial is testing

CellCept (Mycophenolate Mofetil) in Patients With Lupus Nephritis.

Who this might be right for
Lupus Nephritis
Hoffmann-La Roche 52
Next Page